Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome
- PMID: 10984673
- DOI: 10.1016/s0387-7604(00)00143-1
Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome
Abstract
The neurological symptoms of Lesch-Nyhan syndrome (LNS) are assumed to result from the neurotransmitter changes in this disorder. Among them, the dopaminergic system is believed to play a role in the self-injurious behavior through receptor supersensitivity. However, the precise mechanism underlying the dopamine supersensitivity remains unclear. An increased serotonergic action in the striatum may be crucial for the appearance of self-injurious behavior, and pharmacological evidence suggests the efficacy of serotonin agonists/antagonists for the treatment of the self-mutilation in LNS.
Similar articles
-
Self-mutilation in the Lesch-Nyhan syndrome: a corporal consciousness problem?--a new hypothesis.Med Hypotheses. 1998 Jan;50(1):43-7. doi: 10.1016/s0306-9877(98)90176-1. Med Hypotheses. 1998. PMID: 9488181
-
Opiatergic and dopaminergic function and Lesch-Nyhan syndrome.Am J Psychiatry. 1985 Oct;142(10):1226. doi: 10.1176/ajp.142.10.1226a. Am J Psychiatry. 1985. PMID: 2994499 No abstract available.
-
Self-mutilation in Lesch-Nyhan disease is caused by dopaminergic denervation.Lancet. 1985 Feb 9;1(8424):338-9. doi: 10.1016/s0140-6736(85)91107-9. Lancet. 1985. PMID: 2857386 Clinical Trial. No abstract available.
-
Neurobiology of D1 dopamine receptors after neonatal-6-OHDA treatment: relevance to Lesch-Nyhan disease.Adv Exp Med Biol. 1986;204:197-215. doi: 10.1007/978-1-4684-5191-7_13. Adv Exp Med Biol. 1986. PMID: 2947429 Review. No abstract available.
-
Evidence that lack of brain dopamine during development can increase the susceptibility for aggression and self-injurious behavior by influencing D1-dopamine receptor function.Prog Neuropsychopharmacol Biol Psychiatry. 1990;14 Suppl:S65-80. doi: 10.1016/0278-5846(90)90089-y. Prog Neuropsychopharmacol Biol Psychiatry. 1990. PMID: 1982973 Review.
Cited by
-
A model of behavioral treatments for self-mutilation behavior in Lesch-Nyhan syndrome.Neuroreport. 2008 Mar 5;19(4):459-62. doi: 10.1097/WNR.0b013e3282f5f76f. Neuroreport. 2008. PMID: 18287946 Free PMC article.
-
Effect of hypoxanthine, antioxidants and allopurinol on cholinesterase activities in rats.J Neural Transm (Vienna). 2013 Sep;120(9):1359-67. doi: 10.1007/s00702-013-0989-x. Epub 2013 Feb 12. J Neural Transm (Vienna). 2013. PMID: 23400363
-
Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling.J Neurochem. 2013 Dec;127(6):805-18. doi: 10.1111/jnc.12366. Epub 2013 Aug 18. J Neurochem. 2013. PMID: 23859490 Free PMC article.
-
Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.Mol Genet Metab. 2015 Apr;114(4):570-579. doi: 10.1016/j.ymgme.2015.02.007. Epub 2015 Mar 5. Mol Genet Metab. 2015. PMID: 25769394 Free PMC article.
-
Microstructural white matter abnormalities in Lesch-Nyhan disease.Eur J Neurosci. 2022 Jan;55(1):264-276. doi: 10.1111/ejn.15512. Epub 2021 Dec 6. Eur J Neurosci. 2022. PMID: 34738666 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical